5th gen glp 1 agonist GLP-1 Agonists: A Comprehensive Overview GLP-1 Receptor Agonists | New

Some people using GLP-1 RAs have reported side effects

Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain mostbut not allof their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators

Brand names: Ozempic (diabetes), Wegovy (obesity)

To view a copy of this licence, visit About this article Cite this article Zheng, Z., Zong, Y., Ma, Y

In addition, according to observational and experimental data, DPP4 inhibitors [10, 11], sulfonylureas [11, 52], and insulin [53], are unlikely to slow cognitive decline beyond the benefits of glycemic control in diabetes without dementia